DeepBio's Series A Round

DeepBio raised a round of funding on August 13, 2017. Investors include Neoplux.

DeepBio (딥바이오) is a developer of prostate cancer diagnosis software. The company's product features a convolutional neural network that detects and grades prostate cancer from needle biopsy im…

Articles about DeepBio's Series A Round: